Insider · CIK 0001645863
Jason S. Kerr
officer
Files at RXO (RXO, Inc.). First filing Nov 12, 2025, latest Nov 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $386k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RXO: RXO, Inc.
RXOOct 9, 2026 · close 29.08
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | RXOsell RXO, Inc. | $386k 33,343 shares | -43% | 0% from low-63% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 22, 2026 | RXO RXO, Inc. | MOption exercise Common Stock | +2,030 | $0.00 | $0 | 49,325 | Mar 24, 2026 |
| Mar 22, 2026 | RXO RXO, Inc. | FTax withholding Common Stock | -882 | $13.23 | $12k | 48,443 | Mar 24, 2026 |
| Mar 22, 2026 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -2,030 | $0.00 | $0 | 8,982 | Mar 24, 2026 |
| Feb 28, 2026 | RXO RXO, Inc. | MOption exercise Common Stock | +2,036 | $0.00 | $0 | 48,288 | Mar 3, 2026 |
| Feb 28, 2026 | RXO RXO, Inc. | FTax withholding Common Stock | -993 | $15.96 | $16k | 47,295 | Mar 3, 2026 |
| Feb 28, 2026 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -2,036 | $0.00 | $0 | 11,012 | Mar 3, 2026 |
| Feb 23, 2026 | RXO RXO, Inc. | MOption exercise Common Stock | +5,257 | $0.00 | $0 | 48,815 | Feb 25, 2026 |
| Feb 23, 2026 | RXO RXO, Inc. | FTax withholding Common Stock | -2,563 | $14.66 | $38k | 46,252 | Feb 25, 2026 |
| Feb 23, 2026 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -5,257 | $0.00 | $0 | 13,048 | Feb 25, 2026 |
| Nov 10, 2025 | RXO RXO, Inc. | SOpen-market sale Common Stock | -33,343 | $11.57 | $386k | 43,558 | Nov 12, 2025 |
| Oct 3, 2025 | RXO RXO, Inc. | FTax withholding Common Stock | -9,518 | $16.64 | $158k | 76,901 | Oct 7, 2025 |
| Mar 22, 2025 | RXO RXO, Inc. | MOption exercise Common Stock | +2,030 | $0.00 | $0 | 87,307 | Mar 25, 2025 |
| Mar 22, 2025 | RXO RXO, Inc. | FTax withholding Common Stock | -888 | $18.59 | $17k | 86,419 | Mar 25, 2025 |
| Mar 22, 2025 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -2,030 | $0.00 | $0 | 15,422 | Mar 25, 2025 |
| Feb 28, 2025 | RXO RXO, Inc. | AGrant or award Restricted Stock Unitderivative | +2,883 | $0.00 | $0 | 2,883 | Mar 4, 2025 |
| Feb 28, 2025 | RXO RXO, Inc. | AGrant or award Restricted Stock Unitderivative | +6,106 | $0.00 | $0 | 17,452 | Mar 4, 2025 |
| Feb 23, 2025 | RXO RXO, Inc. | MOption exercise Common Stock | +5,256 | $0.00 | $0 | 87,848 | Feb 25, 2025 |
| Feb 23, 2025 | RXO RXO, Inc. | FTax withholding Common Stock | -2,571 | $20.14 | $52k | 85,277 | Feb 25, 2025 |
| Feb 23, 2025 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -5,256 | $0.00 | $0 | 10,514 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.